Shutterstock
DLOC Biosystems has selected Discovery Park, Kent, as the location for its new biology facility. The company will set up a biology lab within Discovery Park’s thriving life science cluster to continue development of its state-of-the-art organ-on-a-chip technology and deliver accurate assay testing services to pharmaceutical companies to advance drug discovery.
DLOC Biosystems was founded to enable faster, safer and cheaper drug development. The company’s chips provide an environment where cells can grow and reorganise into tissues, providing the perfect setting for large scale, affordable drug testing. Its technology will help to enable the reduction and replacement of animal testing, by providing more accurate data on safety and efficacy than current pre-clinical testing models.
With an engineering team based in Lebanon, DLOC was looking to build a new biology team based in the UK. The company selected Discovery Park’s high-spec lab facilities just over an hour from London due to its reputation as a leading hub for life sciences and the opportunity it offers for future expansion. Discovery Park’s extensive ecosystem provides future opportunities for collaboration as well as a network of potential customers, a key consideration for life science start-ups.
Wadah Malaeb, CEO and Founder of DLOC Biosystems, commented: “We were initially interested in locating in London as it offered access to an excellent talent pool, however, the cost and availability of high-spec lab space as well as living costs for potential employees proved inhibitive. When I visited Discovery Park, I was impressed not just by the quality of the facilities available, but also by the extensive business support offered by the team. The park and its surroundings provide an ideal location to build our business and I look forward to joining the Discovery Park community.”